Plant Health Care plc
("Plant Health Care" or "the Company")
Director Dealings / PDMR Shareholding
Plant Health Care, a leading provider of novel patent-protected biological products to global agricultural markets, has been informed that on 27 February 2023, Dr Christopher Richards, Chairman of the Company, transferred 1,487,958 ordinary shares of 0.01 pence each in the capital of the Company ("Ordinary Shares") held by him to an ISA held in the name of him and his wife. This transfer was effected by the sale of 1,487,958 Ordinary Shares at a price of £0.10402 pence per Ordinary Share and the immediate repurchase of 1,487,958 Ordinary Shares at a price of £0.104 per Ordinary Share.
Following this transfer, the total number of Ordinary Shares held by Dr Richards and persons closely associated with him is unchanged and those parties are beneficially interested in 4,285,527 Ordinary Shares, representing approximately 1.4% of the Company's issued share capital.
Enquiries
| Plant Health Care plc | +1 919 926 1600 |
| Jeff Tweedy - CEO | |
| | |
| Cenkos Securities plc - Nomad & Broker Neil McDonald / Peter Lynch | +44 (0) 131 220 9771 |
Company website: www.planthealthcare.com
The information set out below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014.
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||||||||||||||||||||
| a) | Name | Dr Christopher Richards | |||||||||||||||||||
| 2 | Reason for the notification | ||||||||||||||||||||
| a) | Position/status | Chairman | |||||||||||||||||||
| b) | Initial notification/Amendment | Initial notification | |||||||||||||||||||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||||||||||||||||||
| a) | Name | Plant Health Care plc | |||||||||||||||||||
| b) | LEI |
213800KBQPJZ2FM8QH27
| |||||||||||||||||||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||||||||||||||||
| a) | Description of the financial instrument, type of instrument
Identification code | Ordinary Shares of 1p each | |||||||||||||||||||
| b) | Nature of the transaction | 1. Sale of Shares 2. Sale of Shares 3. Purchase of Ordinary Shares 4. Purchase of Ordinary Shares | |||||||||||||||||||
| c) | Price(s) and volume(s) |
| |||||||||||||||||||
| d) | Aggregated information
|
Sale of Ordinary Shares: 1,487,958 Purchase of Ordinary Shares: 1,487,958
Purchase of Ordinary Shares: £0.104 | |||||||||||||||||||
| e) | Date of the transaction | 27.02.2023 | |||||||||||||||||||
| f) | Place of the transaction | AIM, London Stock Exchange | |||||||||||||||||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
